Physician
Toledo Clinic Incorporated
Toledo Clinic Incorporated was paid $15.83M by Medicaid between Jan 2018 and Dec 2024, across 255 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 31% of everything it billed.
33Billing provider infoTOLEDO CLINIC INCORPORATED
TOLEDO, OH 43623
TOLEDO, OH 43623
33aNPI1144217894assigned 09/28/2005
33bProvider typeAllergy Physician
28Total paid$15.83M
24GClaims542,568
24DCodes billed255
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Allergy Physician providers in Ohio
Rank by total paid#1 of 13
Median peer was paid$159K
This provider vs. median100×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 96,248 | $2.75M | |
| 2019 | 93,145 | $2.54M | |
| 2020 | 78,044 | $2.15M | |
| 2021 | 76,385 | $2.39M | |
| 2022 | 63,516 | $2.12M | |
| 2023 | 78,732 | $2.14M | |
| 2024incomplete | 56,498 | $1.74M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 31% | 118,798 | 107,632 | $4.96M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 86,375 | 78,204 | $2.57M |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 6.6% | 63,875 | 23,238 | $1.04M |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 5.8% | 42,614 | 16,898 | $913K |
| 99308 | Subsequent nursing facility care, per day, straightforward | 5.1% | 48,473 | 24,541 | $814K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 3.4% | 6,923 | 6,468 | $541K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 3.0% | 8,585 | 8,089 | $467K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 1.6% | 6,118 | 5,780 | $257K |
| J0585 | Injection, onabotulinumtoxina, 1 unit | 1.6% | 309 | 267 | $246K |
| 99223 | Prolong inpt eval add15 m | 1.4% | 5,119 | 4,652 | $227K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | 1.3% | 1,232 | 1,160 | $200K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.2% | 2,984 | 2,808 | $195K |
243 more codes
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.1% | 8,231 | $167K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 1,972 | $149K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 7,711 | $144K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 2,821 | $133K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 2,109 | $119K |
| 95811 | <1% | 899 | $112K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 6,681 | $108K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 957 | $107K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 3,132 | $107K |
| 88342 | <1% | 1,554 | $97K | |
| 95117 | <1% | 10,581 | $82K | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 1,640 | $81K |
| 64483 | <1% | 1,648 | $78K | |
| 88173 | <1% | 696 | $71K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 2,959 | $71K |
| 31231 | <1% | 876 | $64K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | <1% | 728 | $62K |
| 94060 | <1% | 2,694 | $58K | |
| 11721 | <1% | 4,222 | $54K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 300 | $52K |
| 95165 | Professional services for the supervision of preparation and provision of antigens for allergen immunotherapy, multiple dose vials | <1% | 383 | $51K |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 1,504 | $50K |
| 95819 | <1% | 798 | $45K | |
| 95912 | <1% | 444 | $44K | |
| 95816 | <1% | 1,022 | $44K | |
| 76536 | <1% | 979 | $43K | |
| 95886 | <1% | 1,583 | $42K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,075 | $42K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 735 | $41K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 790 | $40K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 4,455 | $35K |
| 10005 | <1% | 771 | $34K | |
| 99306 | Prolong nursin fac eval 15m | <1% | 1,088 | $32K |
| 93000 | <1% | 3,145 | $30K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 500 | $30K |
| 88172 | <1% | 720 | $29K | |
| 67028 | Intravitreal injection of a pharmacologic agent | <1% | 562 | $28K |
| 94729 | <1% | 2,474 | $27K | |
| 92557 | <1% | 1,213 | $27K | |
| 72100 | <1% | 1,359 | $25K | |
| 36902 | <1% | 417 | $24K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,426 | $23K |
| 92134 | <1% | 2,501 | $22K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 353 | $21K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 1,412 | $21K |
| 17311 | <1% | 111 | $20K | |
| 93970 | <1% | 1,061 | $20K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 452 | $19K |
| 20611 | <1% | 431 | $18K | |
| 17110 | <1% | 440 | $18K | |
| 64612 | <1% | 230 | $18K | |
| 62323 | <1% | 196 | $15K | |
| 94727 | <1% | 1,270 | $14K | |
| 64616 | <1% | 335 | $12K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 276 | $12K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 912 | $12K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 405 | $12K |
| 92567 | <1% | 1,324 | $12K | |
| 64493 | <1% | 312 | $11K | |
| 11102 | <1% | 384 | $11K | |
| 90961 | <1% | 419 | $11K | |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 712 | $11K |
| J3490 | Unclassified drugs | <1% | 104 | $10K |
| 30140 | <1% | 59 | $10K | |
| 64635 | <1% | 126 | $10K | |
| 93971 | <1% | 704 | $10K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 590 | $10K |
| 99254 | <1% | 136 | $9K | |
| 92015 | Determination of refractive state | <1% | 740 | $9K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 1,031 | $9K |
| 62321 | <1% | 101 | $9K | |
| 99310 | Prolong nursin fac eval 15m | <1% | 306 | $8K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 40 | $8K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 1,247 | $8K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 418 | $8K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 72 | $7K |
| 96910 | <1% | 351 | $7K | |
| 99406 | <1% | 902 | $7K | |
| 17312 | <1% | 44 | $6K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 1,791 | $6K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 201 | $6K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,039 | $6K |
| 94726 | <1% | 756 | $6K | |
| 99305 | <1% | 270 | $6K | |
| 64494 | <1% | 288 | $6K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 293 | $5K |
| 92083 | <1% | 273 | $5K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 453 | $5K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 363 | $5K |
| 85018 | <1% | 2,638 | $5K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 362 | $5K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 201 | $5K |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | <1% | 459 | $4K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 568 | $4K |
| 31575 | <1% | 94 | $4K | |
| 90674 | <1% | 173 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,358 | $4K |
| 95911 | <1% | 44 | $4K | |
| 62370 | <1% | 183 | $4K | |
| 10022 | <1% | 128 | $4K | |
| 81002 | <1% | 2,939 | $4K | |
| 96127 | <1% | 1,095 | $3K | |
| 76942 | <1% | 132 | $3K | |
| J9035 | Injection, bevacizumab, 10 mg | <1% | 80 | $3K |
| 70486 | <1% | 32 | $3K | |
| 27096 | <1% | 72 | $3K | |
| 90670 | <1% | 1,009 | $3K | |
| 99442 | <1% | 186 | $3K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 366 | $3K |
| 00731 | <1% | 40 | $3K | |
| 99460 | <1% | 42 | $3K | |
| 95024 | <1% | 72 | $3K | |
| 64636 | <1% | 78 | $3K | |
| 71250 | <1% | 37 | $3K | |
| 90648 | <1% | 1,157 | $3K | |
| 36901 | <1% | 56 | $3K | |
| 90686 | <1% | 890 | $2K | |
| 99497 | <1% | 395 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 308 | $2K |
| 76641 | <1% | 50 | $2K | |
| 93016 | <1% | 173 | $2K | |
| 99205 | Prolong outpt/office vis | <1% | 29 | $2K |
| 99457 | <1% | 78 | $2K | |
| 74018 | <1% | 160 | $2K | |
| 73630 | <1% | 175 | $2K | |
| 90694 | <1% | 110 | $2K | |
| 90688 | <1% | 145 | $2K | |
| 95250 | <1% | 29 | $2K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 82 | $2K |
| 93880 | <1% | 119 | $2K | |
| 99152 | <1% | 526 | $2K | |
| 64484 | <1% | 72 | $2K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 15 | $2K |
| 90723 | <1% | 624 | $2K | |
| 92228 | <1% | 341 | $2K | |
| 11305 | <1% | 78 | $2K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,289 | $2K |
| 11100 | <1% | 39 | $2K | |
| 73620 | <1% | 86 | $2K | |
| 93018 | <1% | 187 | $2K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 14 | $1K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 268 | $1K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,470 | $1K |
| 93923 | <1% | 104 | $1K | |
| 72040 | <1% | 85 | $1K | |
| 99051 | <1% | 77 | $1K | |
| 99307 | <1% | 159 | $1K | |
| 90680 | <1% | 388 | $1K | |
| 73562 | <1% | 103 | $1K | |
| 80305 | <1% | 273 | $1K | |
| 94010 | <1% | 106 | $1K | |
| 76775 | <1% | 41 | $1K | |
| 99490 | Ccm add 20min | <1% | 183 | $1K |
| 92133 | <1% | 111 | $1K | |
| 46600 | <1% | 29 | $1K | |
| 17000 | <1% | 41 | $992.98 | |
| 77080 | <1% | 42 | $959.40 | |
| 90677 | <1% | 103 | $933.78 | |
| 90710 | <1% | 87 | $922.70 | |
| 96367 | <1% | 43 | $906.57 | |
| 80061 | Lipid panel | <1% | 570 | $894.23 |
| 97161 | <1% | 14 | $882.79 | |
| 99221 | <1% | 47 | $866.17 | |
| 99220 | <1% | 13 | $853.92 | |
| 51798 | <1% | 112 | $790.50 | |
| 11755 | <1% | 14 | $774.43 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | <1% | 111 | $760.37 |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 12 | $737.59 |
| 99217 | <1% | 27 | $737.33 | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 295 | $708.92 |
| 90653 | <1% | 44 | $696.29 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 28 | $667.76 |
| 90935 | Hemodialysis procedure with single evaluation by a physician | <1% | 25 | $665.88 |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 29 | $615.67 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 783 | $612.62 |
| 99334 | <1% | 28 | $597.01 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 158 | $594.22 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 423 | $516.69 |
| 90966 | <1% | 13 | $514.70 | |
| 99439 | <1% | 39 | $505.73 | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 19 | $492.43 |
| 36416 | <1% | 755 | $478.49 | |
| G0008 | Administration of influenza virus vaccine | <1% | 241 | $476.17 |
| 90633 | <1% | 131 | $475.19 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 24 | $473.90 |
| 36415 | Collection of venous blood by venipuncture | <1% | 233 | $420.11 |
| 92020 | <1% | 52 | $411.80 | |
| 93227 | <1% | 16 | $352.72 | |
| 87807 | <1% | 49 | $352.22 | |
| 97035 | <1% | 48 | $342.19 | |
| 99441 | <1% | 32 | $325.63 | |
| 84439 | <1% | 244 | $323.35 | |
| 93925 | <1% | 20 | $318.34 | |
| 90685 | <1% | 38 | $280.00 | |
| 81001 | <1% | 498 | $251.12 | |
| 80050 | General health panel | <1% | 88 | $248.93 |
| 20610 | <1% | 14 | $242.35 | |
| 64495 | <1% | 16 | $239.27 | |
| 92250 | <1% | 12 | $235.81 | |
| 90661 | <1% | 12 | $227.76 | |
| 90756 | <1% | 36 | $200.88 | |
| 11720 | <1% | 30 | $185.57 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 18 | $181.50 |
| 73030 | <1% | 13 | $168.15 | |
| 80069 | <1% | 122 | $167.15 | |
| 99153 | Mod sedat endo service >5yrs | <1% | 37 | $140.92 |
| 85027 | <1% | 192 | $134.50 | |
| 92504 | <1% | 14 | $133.13 | |
| 86140 | <1% | 194 | $127.31 | |
| 90734 | <1% | 27 | $110.00 | |
| 92136 | <1% | 17 | $97.91 | |
| 82607 | <1% | 66 | $97.33 | |
| 90962 | <1% | 15 | $90.58 | |
| 90647 | <1% | 17 | $80.00 | |
| 90700 | <1% | 14 | $80.00 | |
| 82565 | <1% | 81 | $76.66 | |
| 82570 | <1% | 105 | $73.49 | |
| 94760 | <1% | 856 | $51.82 | |
| 85652 | <1% | 188 | $49.64 | |
| 90461 | <1% | 472 | $42.00 | |
| 82728 | <1% | 51 | $37.57 | |
| 82948 | <1% | 16 | $35.03 | |
| 83540 | <1% | 70 | $32.07 | |
| 82043 | <1% | 37 | $29.74 | |
| 82746 | <1% | 13 | $28.82 | |
| 83550 | <1% | 53 | $24.08 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 29 | $23.97 |
| 81000 | <1% | 17 | $23.06 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 31 | $22.07 |
| 82962 | <1% | 30 | $19.26 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | <1% | 19 | $2.74 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 18 | $0.60 |
| 90671 | <1% | 15 | $0.13 | |
| 90656 | <1% | 33 | $0.09 | |
| 94660 | 0% | 14 | $0.00 | |
| 99024 | 0% | 260 | $0.00 | |
| 82550 | 0% | 14 | $0.00 | |
| S0280 | Medical home program, comprehensive care coordination and planning, initial plan | 0% | 121 | $0.00 |
| 1101F | 0% | 32 | $0.00 | |
| A4550 | Surgical trays | 0% | 936 | $0.00 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | 0% | 68 | $0.00 |
| 99348 | 0% | 13 | $0.00 | |
| 3288F | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSYLAK, TOM (CHIEF OPERATING OFFICER)
| Provider | Location | Paid |
|---|---|---|
| Toledo Clinic Incorporated | Toledo, OH | $1.98M |
| Toledo Clinic Incorporated | Toledo, OH | $813K |
| Toledo Clinic Incorporated | Monroe, MI | $585K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.